In 30 patients on chronic haemodialysis treatment the platelet activity and function were studied before and during antiplatelet therapy with alpha-tocopherol and sulphinpyrazone. In both kinds of treatment a significant decrease of ADP-induced and spontaneous aggregation was observed. Sulphinpyrazone exerts an inhibitory effect not only on platelet aggregation but also on platelet factor 3 and provokes a significant prolongation of the bleeding time.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/BF02549745 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!